Chronic myelocytic leukemia (CML) is associated with the presence of a Philadelphia (Ph 1) chromosome in 95% of cases (1). This cytogenetic hallmark is molecularly characterized by the translocation of the c-abl oncogene from chromosome 9 into the breakpoint cluster region (bcr) of chromosome 22 (2-5), and the subsequent transcription of a chimeric 8.5 kb bcr/c-abl RNA species within leukemic cells (6-8), which represents mRNA for an altered c-abl protein with associated tyrosine kinase activity (9). PhLnegative CML, however, constitute a heterogeneous group of prognostically distinct disorders (10). Recently (11), my coworkers and I identified a phi-negative CML patient with a c-abl/bcr rearrangement; however, other patients lack this recombination (3). Here I report on the first Phi-negative CML patient whose leukemic cells exhibit a rearrangement in the bcr gene without juxtaposition of c-abl sequences.
to Kodak XAR-5 film using DuPont Lightning Plus intensifying screens for up to 6 d at -70°C.
In Situ Hybridization. Chromosomes obtained from bone marrow were prepared according to standard techniques. After RNase treatment, chromosomes were denatured in 70% formamide/2× standard saline citrate (SSC) at 70°C for 2 rain, rinsed in 2x SSC, and dehydrated. The probe, a 1:1 mixture of human :3' 1.1 kb Hind III/Eco RI and 5' 0.6 kb Bam HI c-abl plasmids (3), was labeled by nick-translation using [~H] dCTP and [3H]dTTP (New England Nuclear, Boston, MA) to a specific activity of 0.8 x 107 cpm/#g. The probe was denatured for 5 min at 70°C at a concentration of 0.2 #g/ml in 50% formamide/2X SSC/10% dextran sulfate added to the chromosomes, and hybridized for 10 h at 37°C; slides were rinsed in three changes of 50% formamide/2× SSC at 39°C, followed by 6 h washing in 2:< SSC at room temperature, exposed to Kodak NTB2 emulsion, for 15 d at 4 ° C, developed, and stained with quinacrine mustard as described (11) .
Results
Southern blot analysis revealed a rearrangement within the bcr gene in leukemic cells of a phi-negative CML patient. Hybridization to 5' bcr sequences detects a 5 kb germline band together with a 3.4 kb rearranged fragment (Fig.  1, lane 2) . A Bgl II polymorphism appears to be an unlikely explanation of this result, since digests using different restriction enzymes (Barn HI, Eco RI, and Hind III) demonstrated a similar pattern (not shown). Hybridization to a 1.2 kb Hind III/Bgl II 3' bcr probe also identified an additional autoradiographic band. These results are comparable to the data obtained in phi-positive CML (e.g., Fig. 1, lane 1) .
T o investigate a possible involvement of c-abl sequences in this genomic alteration, I p e r f o r m e d in situ hybridization studies of c-abl sequences to metaphase chromosomes of the phi-negative CML patient (Table I) . Distribution of silver grains obtained from analysis of 42 metaphases was uniform and at random on all chromosomes except the specific signal (P < 0.01) on chromosome 9. Analysis by Poisson distribution, with the n u m b e r of grains per chromosome adjusted for the relative size of the band in a 400-band idiogram (15), revealed highly significant (P << 10 -7) grain accumulation at band 9q34. Thus, in contrast to all phi-positive CML patients investigated so far (2-4), in situ hybridization studies failed to detect a translocation of c-abl sequences in leukemic cells of this patient.
T o elucidate in some more detail the consequences of these results I p e r f o r m e d FIGURE 1. Southern blot analysis of bcr sequences of human placenta DNA (lane 0) and bone marrow DNA from two leukemic patients (lanes 1 and 2). DNA (15 #g) were digested with Bgl II, electrophoresed on a 0.7% agarose gel, blotted, and hybridized to a Bgl lI/Hind III 5' bcr probe that detects a 5 kb normal bcr fragment. an RNA analysis. Northern blots hybridized to c-abl sequences showed 6 and 7 kb normal abl RNA species, as well as the fused 8.5 kb transcript in Phi-positive CML (Fig. 2A, lane 1) ; in the Phi-negative CML patient, only normal c-abl species were visible (Fig. 2A, lane 2) . Rehybridization of the filters to 5' bcr sequences, however, led to the detection of a novel 7.3 kb bcr transcript in leukemic cells of this individual (Fig. 2B, lane 2) replacing a 6.7 kb normal bcr transcript (8); the 8.5 kb chimeric RNA species (7, 8) demonstrated in Ph 1-positive CML (Fig. 2B, lane 1) . Discussion Molecular analysis of the Ph 1 translocation in CML led to the identification of the bcr gene on chromosome 22. A modification of the c-abl protein by Nterminal substitution of bcr sequences appears to be a crucial event in the development of Phi-positive CML. Chronic myelocytic leukemia without a Ph ~ chromosome comprises a heterogenous group of related disorders. Recent evidence (3, 11) suggests that a subset of cytogenetic Phi-negative CML patients may in fact belong to the molecularly defined entity of Phi-positive CML, while leukemic cells of other Phi-negative CML patients lack a c-abl/bcr rearrangement.
Here I report on yet another type of genomic recombination, i.e., a bcr rearrangement without involvement of c-abl sequences. Data obtained by both in situ hybridization studies and Northern blotting demonstrate that this oncogene is neither translocated nor abnormally transcribed in the Phi-negative CML patient described here. However, a rearrangement within bcr leads to a replacement of normal 4.5 and 6.7 kb bcr RNA species (7) by a novel 7.3 kb transcript in leukemic cells of this individual.
Chronic myelocytic leukemia is a clonal disease of pluripotent hematopoietic stem cells, and the expression of bcr may be closely associated with this cell lineage. However, the normal function of the bcr-encoded product is still unknown. The detection of a rearrangement within bcr per se is in all likelihood not a sufficient explanation for the development of myeloid leukemia. As for the patient described herein, it may be possible that bcr sequences are fused with other, yet unknown sequences, instead of c-abl. Molecular cloning and detailed analysis of the novel bcr transcript may substantiate this speculation. However, the demonstration of heterogeneity among phi-negative CML cases detected by bcr and c-abl sequences may finally contribute to a novel subclassification of this poorly defined group of leukemias based on molecular, morphological, and clinical features.
Summary
Southern blot analysis detected a bcr gene rearrangement within leukemic cells of a Philadelphia chromosome-negative chronic myelocytic leukemia (CML) patient that led to transcription of a novel 7.3 kb bcr RNA species. Participation of the c-abl oncogene in this genomic recombination could be ruled out by in situ hybridization studies and Northern blot analysis. I thank Dr. F. Carbonell for cell samples as well as clinical and cytogenetic data of patients, and Drs. A. de Klein, N. Heisterkamp, G. Grosveld, and J. Groffen for c-abl and bcr probes and for helpful discussions.
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